Accuracy and reliability of continuous blood glucose monitoring during pediatric cardiopulmonary bypass. 2019

Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
Department of Community Medicine and Human Resource Development, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto, Tokushima, 770-8503, Japan. kawahito.shinji@tokushima-u.ac.jp.

The purpose of this study was to assess the accuracy and reliability of a continuous blood glucose monitoring system (artificial endocrine pancreas; STG-55, Nikkiso, Tokyo, Japan) during pediatric cardiopulmonary bypass surgery. Twenty-five pediatric patients scheduled to undergo cardiovascular surgery with cardiopulmonary bypass (age 4 months to 11 years; body weight 5.6-59.7 kg) were enrolled. The glucose sensor line of the artificial endocrine pancreas was connected to the venous side of the cardiopulmonary bypass circuit and used for continuous blood glucose monitoring. We obtained 192 samples for blood gas assessment from the cardiopulmonary bypass circuit, and i-STAT (Abbott, East Windsor, NJ, USA) was used for conventional blood glucose assessment. The accuracies of continuous glucose measurements (STG-55) and conventional intermittent glucose measurements (i-STAT) during cardiopulmonary bypass were compared by means of Clarke error grid analysis. The results were divided into five zones, A, B, C, D, and E, and 78.6% of paired measurements were in zone A, while 21.4% were in zone B. We confirmed that the results of this continuous blood glucose monitoring system for cardiopulmonary bypass during pediatric cardiovascular surgery were highly reliable. An artificial endocrine pancreas may facilitate the safe use of intensive insulin therapy during pediatric cardiovascular surgery.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007332 Insulin Infusion Systems Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor. Pancreas, Artificial Endocrine,Programmable Implantable Insulin Pump,beta Cell, Artificial,Implantable Programmable Insulin Pump,Insulin Pump, Programmable Implantable,Pump, Programmable Implantable Insulin,Artificial Endocrine Pancreas,Artificial beta Cell,Artificial beta Cells,Cell, Artificial beta,Cells, Artificial beta,Endocrine Pancreas, Artificial,Infusion System, Insulin,Infusion Systems, Insulin,Insulin Infusion System,System, Insulin Infusion,Systems, Insulin Infusion,beta Cells, Artificial
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006330 Heart Defects, Congenital Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life. Congenital Heart Disease,Heart Abnormalities,Abnormality, Heart,Congenital Heart Defect,Congenital Heart Defects,Defects, Congenital Heart,Heart Defect, Congenital,Heart, Malformation Of,Congenital Heart Diseases,Defect, Congenital Heart,Disease, Congenital Heart,Heart Abnormality,Heart Disease, Congenital,Malformation Of Heart,Malformation Of Hearts
D006348 Cardiac Surgical Procedures Surgery performed on the heart. Cardiac Surgical Procedure,Heart Surgical Procedure,Heart Surgical Procedures,Procedure, Cardiac Surgical,Procedure, Heart Surgical,Procedures, Cardiac Surgical,Procedures, Heart Surgical,Surgical Procedure, Cardiac,Surgical Procedure, Heart,Surgical Procedures, Cardiac,Surgical Procedures, Heart

Related Publications

Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
September 1991, The Journal of thoracic and cardiovascular surgery,
Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
February 1996, Masui. The Japanese journal of anesthesiology,
Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
May 2019, Journal of diabetes science and technology,
Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
July 2017, IEEE transactions on bio-medical engineering,
Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
December 1993, Anesthesia and analgesia,
Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
February 1992, Journal of cardiothoracic and vascular anesthesia,
Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
January 2013, Perfusion,
Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
January 2006, ASAIO journal (American Society for Artificial Internal Organs : 1992),
Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
January 2006, Perfusion,
Shinji Kawahito, and Naoji Mita, and Tomohiro Soga, and Shusuke Yagi, and Nami Kakuta, and Shiho Satomi, and Hiroyuki Kinoshita, and Kazumi Takaishi, and Tetsuya Kitagawa, and Hiroshi Kitahata
August 2009, Diabetes technology & therapeutics,
Copied contents to your clipboard!